Since its identification in China in December 2019, the novel coronavirus COVID-19 has rapidly evolved into a pandemic. COVID-19 manifests with non-specific respiratory symptoms of variable severity and may require advanced respiratory support. The diagnosis of COVID-19 is currently confirmed by laborato...

Texto completo (enlace principal)     Texto completo (enlace alternativo)     Texto completo (enlace alternativo)     Texto completo (enlace alternativo)     Texto completo (enlace alternativo)     Texto completo (enlace alternativo)    

The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...

Texto completo

This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....

Texto completo

Communicable diseases are currently the leading cause of preventable deaths worldwide, disproportionately affecting resource-poor settings. Pandemic influenza would add to already unacceptable levels of morbidity and mortality from diarrhoea, malaria, pneumonia, malnutrition, HIV/AIDS and tuberculosis, i...

Texto completo